Sodium Bicarbonate Therapy in Patients with Metabolic Acidosis (2024)

1. Aiken C. G. A. History of medical understanding and misunderstanding of acid base balance. Journal of Clinical and Diagnostic Research. 2013;7(9):2038–2041. doi:10.7860/JCDR/2013/5230.3400. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

2. Berend K. Acid-base pathophysiology after 130 years: confusing, irrational and controversial. Journal of Nephrology. 2013;26(2):254–265. doi:10.5301/jn.5000191. [PubMed] [CrossRef] [Google Scholar]

3. Nasir N. M., Sthaneshwar P., Yunus P. J. M., Yap S.-F. Comparing measured total carbon dioxide and calculated bicarbonate. The Malaysian Journal of Pathology. 2010;32(1):21–26. [PubMed] [Google Scholar]

4. Sly W. S., Hu P. Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annual Review of Biochemistry. 1995;64:375–401. doi:10.1146/annurev.bi.64.070195.002111. [PubMed] [CrossRef] [Google Scholar]

5. Kumar V., Karon B. S. Comparison of measured and calculated bicarbonate values. Clinical Chemistry. 2008;54(9):1586–1587. doi:10.1373/clinchem.2008.107441. [PubMed] [CrossRef] [Google Scholar]

6. Posner J. B., Plum F. Spinal-fluid pH and neurologic symptoms in systemic acidosis. The New England Journal of Medicine. 1967;277(12):605–613. doi:10.1056/NEJM196709212771201. [PubMed] [CrossRef] [Google Scholar]

7. Cingolani H. E., Faulkner S. L., Mattiazzi A. R., Bender H. W., Graham T. P., Jr. Depression of human myocardial contractility with “respiratory” and “metabolic” acidosis. Surgery. 1975;77(3):427–432. [PubMed] [Google Scholar]

8. Gehlbach B. K., Schimdt G. A. Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit—the role of buffers. Critical Care. 2004;8(4):259–265. doi:10.1186/cc2865. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

9. Schotola H., Toischer K., Popov A. F., Renner A., Schmitto J. D., Gummert J., Quintel M., Bauer M., Maier L. S., Sossalla S. Mild metabolic acidosis impairs the β-adrenergic response in isolated human failing myocardium. Critical Care. 2012;16(4, article R153) doi:10.1186/cc11468. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

10. Forsythe S. M., Schmidt G. A. Sodium bicarbonate for the treatment of lactic acidosis. Chest. 2000;117(1):260–267. doi:10.1378/chest.117.1.260. [PubMed] [CrossRef] [Google Scholar]

11. Cooper D. J., Worthley L. I. G. Adverse haemodynamic effects of sodium bicarbonate in metabolic acidosis. Intensive Care Medicine. 1987;13(6):425–427. doi:10.1007/BF00257690. [PubMed] [CrossRef] [Google Scholar]

12. Ammari A. N., Schulze K. F. Uses and abuses of sodium bicarbonate in the neonatal intensive care unit. Current Opinion in Pediatrics. 2002;14(2):151–156. doi:10.1097/00008480-200204000-00002. [PubMed] [CrossRef] [Google Scholar]

13. Aschner J. L., L.Poland R. Sodium bicarbonate: basically useless therapy. Pediatrics. 2008;122(4):831–835. doi:10.1542/peds.2007-2400. [PubMed] [CrossRef] [Google Scholar]

14. Wilson R. F., Spencer A. R., Tyburski J. G., Dolman H., Zimmerman L. H. Bicarbonate therapy in severely acidotic trauma patients increases mortality. Journal of Trauma and Acute Care Surgery. 2013;74(1):45–50. doi:10.1097/TA.0b013e3182788fc4. [PubMed] [CrossRef] [Google Scholar]

15. Waters W. C., III, Hall J. D., Schwartz W. B. Spontaneous lactic acidosis. The nature of the acid-base disturbance and considerations in diagnosis and management. The American Journal of Medicine. 1963;35(6):781–793. doi:10.1016/0002-9343(63)90240-7. [PubMed] [CrossRef] [Google Scholar]

16. Roth G. J., Porte D., Jr. Chronic lactic acidosis and acute leukemia. Archives of Internal Medicine. 1970;125(2):317–321. doi:10.1001/archinte.125.2.317. [PubMed] [CrossRef] [Google Scholar]

17. Wainer R. A., Wiernik P. H., Thompson W. L. Metabolic and therapeutic studies of a patient with acute leukemia and severe lactic acidosis of prolonged duration. The American Journal of Medicine. 1973;55(2):255–260. doi:10.1016/0002-9343(73)90177-0. [PubMed] [CrossRef] [Google Scholar]

18. Fraley D. S., Adler S., Bruns F. J., Zett B. Stimulation of lactate production by administration of bicarbonate in a patient with a solid neoplasm and lactate acidosis. The New England Journal of Medicine. 1980;303(19):1100–1102. doi:10.1056/NEJM198011063031907. [PubMed] [CrossRef] [Google Scholar]

19. Fields A. L. A., Wolman S. L., Halperin M. L. Chronic lactic acidosis in a patient with cancer: therapy and metabolic consequences. Cancer. 1981;47(8):2026–2029. [PubMed] [Google Scholar]

20. Stacpoole P. W., Harman E. M., Curry S. H., Baumgartner T. G., Misbin R. I. Treatment of lactic acidosis with dichloroacetate. The New England Journal of Medicine. 1983;309(7):390–396. doi:10.1056/NEJM198308183090702. [PubMed] [CrossRef] [Google Scholar]

21. Cooper D. J., Walley K. R., Wiggs B. R., Russell J. A. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Annals of Internal Medicine. 1990;112(7):492–498. doi:10.7326/0003-4819-112-7-492. [PubMed] [CrossRef] [Google Scholar]

22. Mathieu D., Neviere R., Billard V., Fleyfel M., Wattel F. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Critical Care Medicine. 1991;19(11):1352–1356. doi:10.1097/00003246-199111000-00008. [PubMed] [CrossRef] [Google Scholar]

23. Assal J. P., Aoki T. T., Manzano F. M., Kozak G. P. Metabolic effects of sodium bicarbonate in management of diabetic ketoacidosis. Diabetes. 1974;23(5):405–411. [PubMed] [Google Scholar]

24. Lutterman J. A., Adriaansen A. A. J., van't Laar A. Treatment of severe diabetic ketoacidosis. A comparative study of two methods. Diabetologia. 1979;17(1):17–21. doi:10.1007/BF01222972. [PubMed] [CrossRef] [Google Scholar]

25. Lever E., Jaspan J. B. Sodium bicarbonate therapy in severe diabetic ketoacidosis. The American Journal of Medicine. 1983;75(2):263–268. doi:10.1016/0002-9343(83)91203-2. [PubMed] [CrossRef] [Google Scholar]

26. Hale P. J., Crase J., Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. The British Medical Journal. 1984;289(6451):1035–1038. doi:10.1136/bmj.289.6451.1035. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

27. Morris L. R., Murphy M. B., Kitabchi A. E. Bicarbonate therapy in severe diabetic ketoacidosis. Annals of Internal Medicine. 1986;105(6):836–840. doi:10.7326/0003-4819-105-6-836. [PubMed] [CrossRef] [Google Scholar]

28. Gamba G., Oseguera J., Castrejon M., Gomez-Perez F. J. Bicarbonate therapy in severe diabetic ketoacidosis. A double blind, randomized, placebo controlled trial. Revista de Investigacion Clinica. 1991;43(3):234–238. [PubMed] [Google Scholar]

29. Green S. M., Rothrock S. G., Ho J. D., Gallant R. D., Borger R., Thomas T. L., Zimmerman G. J. Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Annals of Emergency Medicine. 1998;31(1):41–48. doi:10.1016/S0196-0644(98)70279-3. [PubMed] [CrossRef] [Google Scholar]

30. Viallon A., Zeni F., Lafond P., Venet C., Tardy B., Page Y., Bertrand J.-C. Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Critical Care Medicine. 1999;27(12):2690–2693. doi:10.1097/00003246-199912000-00014. [PubMed] [CrossRef] [Google Scholar]

31. Latif K. A., Freire A. X., Kitabchi A. E., Umpierrez G. E., Qureshi N. The use of alkali therapy in severe diabetic ketoacidosis. Diabetes Care. 2002;25(11):2113–2114. doi:10.2337/diacare.25.11.2113. [PubMed] [CrossRef] [Google Scholar]

32. Kitabchi A. E., Umpierrez G. E., Miles J. M., Fisher J. N. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–1343. doi:10.2337/dc09-9032. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

33. Chua H. R., Schneider A., Bellomo R. Bicarbonate in diabetic ketoacidosis—a systematic review. Annals of Intensive Care. 2011;1:23. [PMC free article] [PubMed] [Google Scholar]

34. Duhon B., Attridge R. L., Franco-Martinez A. C., Maxwell P. R., Hughes D. W. Intravenous sodium bicarbonate therapy in severely acidotic diabetic ketoacidosis. Annals of Pharmacotherapy. 2013;47(7-8):970–975. doi:10.1345/aph.1S014. [PubMed] [CrossRef] [Google Scholar]

35. Stacpoole P. W., Kerr D. S., Barnes C., Bunch S. T., Carney P. R., Fennell E. M., Felitsyn N. M., Gilmore R. L., Greer M., Henderson G. N., Hutson A. D., Neiberger R. E., O'Brien R. G., Perkins L. A., Quisling R. G., Shroads A. L., Shuster J. J., Silverstein J. H., Theriaque D. W., Valenstein E. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics. 2006;117(5):1519–1531. doi:10.1542/peds.2005-1226. [PubMed] [CrossRef] [Google Scholar]

36. Luft D., Schmuelling R. M., Eggstein M. Lactic acidosis in biguanide-treated diabetics: a review of 330 cases. Diabetologia. 1978;14(2):75–87. doi:10.1007/BF01263444. [PubMed] [CrossRef] [Google Scholar]

37. Kim H. J., Son Y. K., An W. S. Effect of sodium bicarbonate administration on mortality in patients with lactic acidosis: a retrospective analysis. PLoS ONE. 2013;8(6) doi:10.1371/journal.pone.0065283.e65283 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

38. El-Solh A. A., Abou Jaoude P., Porhomayon J. Bicarbonate therapy in the treatment of septic shock: a second look. Internal and Emergency Medicine. 2010;5(4):341–347. doi:10.1007/s11739-010-0351-3. [PubMed] [CrossRef] [Google Scholar]

39. Fang Z. X., Li Y. F., Zhou X. Q., Zhang Z., Zhang J. S., Xia H. M., Xing G. P., Shu W. P., Shen L., Yin G. Q. Effects of resuscitation with crystalloid fluids on cardiac function in patients with severe sepsis. BMC infectious diseases. 2008;8, article 50 doi:10.1186/1471-2334-8-50. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

40. Boyd J. H., Walley K. R. Is there a role for sodium bicarbonate in treating lactic acidosis from shock? Current Opinion in Critical Care. 2008;14(4):379–383. doi:10.1097/MCC.0b013e3283069d5c. [PubMed] [CrossRef] [Google Scholar]

41. Mark N. H., Leung J. M., Arieff A. I., et al. Safety of low-dose intraoperative bicarbonate therapy: a prospective, double-blind, randomized study. Critical Care Medicine. 1993;21(5):659–665. doi:10.1097/00003246-199305000-00007. [PubMed] [CrossRef] [Google Scholar]

42. Hewitt J., Uniacke M., Hansi N. K., Venkat-Raman G., McCarthy K. Sodium bicarbonate supplements for treating acute kidney injury. Cochrane Database of Systematic Reviews. 2012;6CD009204 [PMC free article] [PubMed] [Google Scholar]

43. Kidney disease: improving Global Outcomes (KDIGO). Chronic kidney disease work group. KDIGO 2012 clinical practice guidelina for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013;3(4) doi:10.1038/kisup.2012.76. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

44. Roderick P., Willis N. S., Blakeley S., Jones C., Tomson C. Correction of chronic metabolic acidosis for chronic kidney disease patients. Cochrane Database of Systematic Reviews. 2007;24(1)CD001890 [PMC free article] [PubMed] [Google Scholar]

45. Susantitaphong P., Sewaralthahab K., Balk E. M., Jaber B. L., Madias N. E. Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review. American Journal of Nephrology. 2012;35(6):540–547. doi:10.1159/000339329. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

46. Eustace J. A., Astor B., Muntner P. M., Ikizler T. A., Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney International. 2004;65(3):1031–1040. doi:10.1111/j.1523-1755.2004.00481.x. [PubMed] [CrossRef] [Google Scholar]

47. Hsu C.-Y., Chertow G. M. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrology Dialysis Transplantation. 2002;17(8):1419–1425. doi:10.1093/ndt/17.8.1419. [PubMed] [CrossRef] [Google Scholar]

48. Moranne O., Froissart M., Rossert J., Gauci C., Boffa J.-J., Haymann J. P., M'rad M. B., Jacquot C., Houillier P., Stengel B., Fouqueray B., Ronco P., Urena P., Rougier J.-P., Plaisier E., Fysekidis M., Vrtovsnik F., Flamant M., Essig M., De La Faille R., D'Auzac C., Karras A., Briet M., Maruani G., Lefaucheur C., Nicolet-Barousse L. Timing of onset of CKD-related metabolic complications. Journal of the American Society of Nephrology. 2009;20(1):164–171. doi:10.1681/ASN.2008020159. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

49. Wallia R., Greenberg A., Piraino B., Mitro R., Puschett J. B. Serum electrolyte patterns in end-stage renal disease. American Journal of Kidney Diseases. 1986;8(2):98–104. doi:10.1016/S0272-6386(86)80119-6. [PubMed] [CrossRef] [Google Scholar]

50. Hakim R. M., Lazarus J. M. Biochemical parameters in chronic renal failure. American Journal of Kidney Diseases. 1988;11(3):238–247. doi:10.1016/S0272-6386(88)80156-2. [PubMed] [CrossRef] [Google Scholar]

51. Dobre M., Yang W., Chen J., et al. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. American Journal of Kidney Diseases. 2013;62(4):670–678. doi:10.1053/j.ajkd.2013.01.017. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

52. Widmer B., Gerhardt R. E., Harrington J. T., Cohen J. J. Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure. Archives of Internal Medicine. 1979;139(10):1099–1102. doi:10.1001/archinte.139.10.1099. [PubMed] [CrossRef] [Google Scholar]

53. Story D. A., Tosolini A., Bellomo R., Leblanc M., Bragantini L., Ronco C. Plasma acid-base changes in chronic renal failure: a Stewart analysis. International Journal of Artificial Organs. 2005;28(10):961–965. [PubMed] [Google Scholar]

54. Abramowitz M. K., Hostetter T. H., Melamed M. L. The serum anion gap is altered in early kidney disease and associates with mortality. Kidney International. 2012;82(6):701–709. doi:10.1038/ki.2012.196. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

55. de Santo N. G., Capasso G., Malnic G., Anastasio P., Spitali L., D'Angelo A. Effect of an acute oral protein load on renal acidification in healthy humans and in patients with chronic renal failure. Journal of the American Society of Nephrology. 1997;8(5):784–792. [PubMed] [Google Scholar]

56. Bosch J. P., Saccaggi A., Lauer A., Ronco C., Belledonne M., Glabman S. Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate. The American Journal of Medicine. 1983;75(6):943–950. doi:10.1016/0002-9343(83)90873-2. [PubMed] [CrossRef] [Google Scholar]

57. Kontessis P., Jones S., Dodds R., Trevisan R., Nosadini R., Fioretto P., Borsato M., Sacerdoti D., Viberti G. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney International. 1990;38(1):136–144. doi:10.1038/ki.1990.178. [PubMed] [CrossRef] [Google Scholar]

58. Azadbakht L., Atabak S., Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care. 2008;31(4):648–654. doi:10.2337/dc07-2065. [PubMed] [CrossRef] [Google Scholar]

59. Berkemeyer S., Vormann J., Günther A. L. B., Rylander R., Frassetto L. A., Remer T. Renal net acid excretion capacity is comparable in prepubescence, adolescence, and young adulthood but falls with aging. Journal of the American Geriatrics Society. 2008;56(8):1442–1448. doi:10.1111/j.1532-5415.2008.01799.x. [PubMed] [CrossRef] [Google Scholar]

60. Amodu A., Abramowitz M. K. Dietary acid, age, and serum bicarbonate levels among adults in the United States. Clinical Journal of the American Society of Nephrology. 2013;8(12):2034–2042. doi:10.2215/CJN.03600413. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

61. Gennari F. J., Hood V. L., Greene T., Wang X., Levey A. S. Effect of dietary protein intake on serum total CO2 concentration in chronic kidney disease: modification of Diet in Renal Disease study findings. Clinical journal of the American Society of Nephrology. 2006;1(1):52–57. doi:10.2215/CJN.00060505. [PubMed] [CrossRef] [Google Scholar]

62. Scialla J. J., Appel L. J., Astor B. C., Miller E. R., III, Beddhu S., Woodward M., Parekh R. S., Anderson C. A. M. Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease. Clinical Journal of the American Society of Nephrology. 2011;6(7):1526–1532. doi:10.2215/CJN.00150111. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

63. van den Berg E., Engberink M. F., Brink E. J., et al. Dietary acid load and metabolic acidosis in renal transplant recipients. Clinical Journal of the American Society of Nephrology. 2012;7(11):1811–1818. doi:10.2215/CJN.04590512. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

64. Kovesdy C. P., Anderson J. E., Kalantar-Zadeh K. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrology Dialysis Transplantation. 2009;24(4):1232–1237. doi:10.1093/ndt/gfn633. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

65. Kovesdy C. P. Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD? Nephrology Dialysis Transplantation. 2012;27(8):3056–3062. doi:10.1093/ndt/gfs291. [PubMed] [CrossRef] [Google Scholar]

66. Chen W., Abramowitz M. K. Metabolic acidosis and the progression of chronic kidney disease. BMC Nephrology. 2014;15(1, article 55) doi:10.1186/1471-2369-15-55. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

67. Shah S. N., Abramowitz M., Hostetter T. H., Melamed M. L. Serum bicarbonate levels and the progression of kidney disease: a cohort study. American Journal of Kidney Diseases. 2009;54(2):270–277. doi:10.1053/j.ajkd.2009.02.014. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

68. Raphael K. L., Wei G., Baird B. C., Greene T., Beddhu S. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney International. 2011;79(3):356–362. doi:10.1038/ki.2010.388. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

69. Scialla J. J., Appel L. J., Astor B. C., Miller E. R., III, Beddhu S., Woodward M., Parekh R. S., Anderson C. A. M. Net endogenous acid production is associated with a faster decline in GFR in African Americans. Kidney International. 2012;82(1):106–112. doi:10.1038/ki.2012.82. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

70. Kanda E., Ai M., Yoshida M., Kuriyama R., Shiigai T. High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients. BMC Nephrology. 2013;14(1, article 4) doi:10.1186/1471-2369-14-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

71. Goldenstein L., Driver T. H., Fried L. F., Rifkin D. E., Patel K. V., Yenchek R. H. Serum bicarbonate concentrations and kidney disease progression in community-living elders: the health, aging, and body composition (Health ABC) study. American Journal of Kidney Diseases. 2014 doi:10.1053/j.ajkd.2014.05.009. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

72. Driver T. H., Shlipak M. G., Katz R., et al. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA) American Journal of Kidney Diseases. 2014 doi:10.1053/j.ajkd.2014.05.008. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

73. de Brito-Ashurst I., Varagunam M., Raftery M. J., Yaqoob M. M. Bicarbonate supplementation slows progression of CKD and improves nutritional status. Journal of the American Society of Nephrology. 2009;20(9):2075–2084. doi:10.1681/ASN.2008111205. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

74. Kovesdy C. P., Kalantar-Zadeh K. Oral bicarbonate: renoprotective in CKD? Nature Reviews Nephrology. 2010;6(1):15–17. doi:10.1038/nrneph.2009.204. [PubMed] [CrossRef] [Google Scholar]

75. Phisitkul S., Khanna A., Simoni J., Broglio K., Sheather S., Rajab M. H., Wesson D. E. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney International. 2010;77(7):617–623. doi:10.1038/ki.2009.519. [PubMed] [CrossRef] [Google Scholar]

76. Mahajan A., Simoni J., Sheather S. J., Broglio K. R., Rajab M. H., Wesson D. E. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney International. 2010;78(3):303–309. doi:10.1038/ki.2010.129. [PubMed] [CrossRef] [Google Scholar]

77. Goraya N., Simoni J., Jo C., Wesson D. E. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney International. 2012;81(1):86–93. doi:10.1038/ki.2011.313. [PubMed] [CrossRef] [Google Scholar]

78. di Iorio B., Aucella F., Conte G., Cupisti A., Santoro D. A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study. Journal of Nephrology. 2012;25(3):437–440. doi:10.5301/jn.5000014. [PubMed] [CrossRef] [Google Scholar]

79. Gaggl M., Cejka D., Plischke M., Heinze G., Fraunschiel M., Schmidt A., Hörl W. H., Sunder-Plassmann G. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study) Trials. 2013;14(1, article 196) doi:10.1186/1745-6215-14-196. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

80. Alkali Therapy in Chronic Kidney Disease. 2014. [Google Scholar]

81. Libório A. B., Daher E. F., de Castro M. C. M. Characterization of acid-base status in maintenance hemodialysis: physicochemical approach. Journal of Artificial Organs. 2008;11(3):156–159. doi:10.1007/s10047-008-0419-2. [PubMed] [CrossRef] [Google Scholar]

82. Marques F. O., Liborio A. B., Daher E. F. Effect of chloride dialysate concentration on metabolic acidosis in maintenance hemodialysis patients. Brazilian Journal of Medical and Biological Research. 2010;43(10):996–1000. doi:10.1590/S0100-879X2010007500094. [PubMed] [CrossRef] [Google Scholar]

83. Tentori F., Karaboyas A., Robinson B. M., Morgenstern H., Zhang J., Sen A., Ikizler T. A., Rayner H., Fissell R. B., Vanholder R., Tomo T., Port F. K. Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) American Journal of Kidney Diseases. 2013;62(4):738–746. doi:10.1053/j.ajkd.2013.03.035. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

84. Gabutti L., Ferrari N., Giudici G., Mombelli G., Marone C. Unexpected haemodynamic instability associated with standard bicarbonate haemodialysis. Nephrology Dialysis Transplantation. 2003;18(11):2369–2376. doi:10.1093/ndt/gfg383. [PubMed] [CrossRef] [Google Scholar]

85. Uribarri J., Levin N. W., Delmez J., Depner T. A., Ornt D., Owen W., Yan G. Association of acidosis and nutritional parameters in hemodialysis patients. The American Journal of Kidney Diseases. 1999;34(3):493–499. doi:10.1016/S0272-6386(99)70077-6. [PubMed] [CrossRef] [Google Scholar]

86. Bommer J., Locatelli F., Satayathum S., Keen M. L., Goodkin D. A., Saito A., Akiba T., Port F. K., Young E. W. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS) American Journal of Kidney Diseases. 2004;44(4):661–671. doi:10.1053/j.ajkd.2004.06.008. [PubMed] [CrossRef] [Google Scholar]

87. Lin S.-H., Lin Y.-F., Chin H.-M., Wu C.-C. Must metabolic acidosis be associated with malnutrition in haemodialysed patients? Nephrology Dialysis Transplantation. 2002;17(11):2006–2010. doi:10.1093/ndt/17.11.2006. [PubMed] [CrossRef] [Google Scholar]

88. Wu D. Y., Shinaberger C. S., Regidor D. L., McAllister C. J., Kopple J. D., Kalantar-Zadeh K. Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic? Clinical Journal of the American Society of Nephrology. 2006;1(1):70–78. doi:10.2215/CJN.00010505. [PubMed] [CrossRef] [Google Scholar]

89. Lowrie E. G., Lew N. L. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. American Journal of Kidney Diseases. 1990;15(5):458–482. doi:10.1016/S0272-6386(12)70364-5. [PubMed] [CrossRef] [Google Scholar]

90. Chiu Y. W., Kopple J. D., Mehrotra R. Correction of metabolic acidosis to ameliorate wasting in chronic kidney disease: goals and strategies. Seminars in Nephrology. 2009;29(1):67–74. doi:10.1016/j.semnephrol.2008.10.009. [PubMed] [CrossRef] [Google Scholar]

91. Fresenius Medical Care North America Medical Office . Dialysate Bicarbonate. 2012. http://www.renalweb.com/writings/alkalosis/FMC%20Jul%2025%202012.pdf. [Google Scholar]

93. Al-Abri S. A., Kearney T. Baking soda misuse as a home remedy: case experience of the California Poison Control System. Journal of Clinical Pharmacy and Therapeutics. 2014;39(1):73–77. doi:10.1111/jcpt.12113. [PubMed] [CrossRef] [Google Scholar]

94. Husted F. C., Nolph K. D., Maher J. F. NaHCO3 and NaC1 tolerance in chronic renal failure. The Journal of Clinical Investigation. 1975;56(2):414–419. doi:10.1172/JCI108107. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

95. Soler N. G., Bennett M. A., Dixon K., FitzGerald M. G., Malins J. M. Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. The Lancet. 1972;2(7779):665–667. [PubMed] [Google Scholar]

96. Hughes W. S., Aurbach G. D., Sharp M. E., Marx S. J. The effect of the bicarbonate anion on serum ionized calcium concentration in vitro. Journal of Laboratory and Clinical Medicine. 1984;103(1):93–103. [PubMed] [Google Scholar]

97. Singer R. B., Deering R. C., Clark J. K. The acute effects in man of a rapid intravenous infusion of hypertonic sodium bicarbonate solution. II. Changes in respiration and output of carbon dioxide. The Journal of Clinical Investigation. 1956;35(2):245–253. doi:10.1172/JCI103269. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

98. Ryder R. E. J. Lactic acidosis: high-dose or low-dose bicarbonate therapy. Diabetes Care. 1984;7(1):99–102. [PubMed] [Google Scholar]

99. Bersin R. M., Chatterjee K., Arieff A. I. Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. The American Journal of Medicine. 1989;87(1):7–14. doi:10.1016/S0002-9343(89)80476-0. [PubMed] [CrossRef] [Google Scholar]

100. Hindman B. J. Sodium bicarbonate in the treatment of subtypes of acute lactic acidosis: physiologic considerations. Anesthesiology. 1990;72(6):1064–1076. doi:10.1097/00000542-199006000-00018. [PubMed] [CrossRef] [Google Scholar]

101. Nakashima K., Yamash*ta T., Kashiwagi S., Nakayama N., Kitahara T., Ito H. The effect of sodium bicarbonate on CBF and intracellular pH in man: stable Xe-CT and 31P-MRS. Acta Neurologica Scandinavica. 1996;93(supplement s166):96–98. doi:10.1111/j.1600-0404.1996.tb00561.x. [PubMed] [CrossRef] [Google Scholar]

102. Symreng T., Flanigan M. J., Lim V. S. Ventilatory and metabolic changes during high efficiency hemodialysis. Kidney International. 1992;41(4):1064–1069. doi:10.1038/ki.1992.162. [PubMed] [CrossRef] [Google Scholar]

103. Sombolos K. I., Bamichas G. I., Christidou F. N., Gionanlis L. D., Karagianni A. C., Anagnostopoulos T. C., Natse T. A. pO2 and pCO2 increment in post-dialyzer blood: the role of dialysate. Artificial Organs. 2005;29(11):892–898. doi:10.1111/j.1525-1594.2005.00126.x. [PubMed] [CrossRef] [Google Scholar]

104. Alfakir M., Moammar M. Q., Ali M. I., Alhatem E., Curran R. D., Saoud R. M., Chandran C., Khan M. A., DeBari V. A. Pulmonary gas exchange during hemodialysis: a comparison of subjects with and without COPD on bicarbonate hemodialysis. Annals of Clinical and Laboratory Science. 2011;41(4):315–320. [PubMed] [Google Scholar]

105. Graziani G., Casati S., Passerini P., Crepaldi M., Campise M., Ambroso G. Pathophysiology and clinical consequences of metabolic alkalosis in hemodialyzed patients. Archivio Italiano di Urologia Nefrologia Andrologia. 1987;59(2):105–111. [PubMed] [Google Scholar]

106. Di Iorio B., Torraca S., Piscopo C., Sirico M. L., Di Micco L., Pota A., Tartaglia D., Berardino L., Morrone L. F., Russo D. Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects. Journal of Nephrology. 2012;25(5):653–660. doi:10.5301/jn.5000036. [PubMed] [CrossRef] [Google Scholar]

107. Goodman W. G., London G. Vascular calcification in chronic kidney disease. The American Journal of Kidney Diseases. 2004;43(3):572–579. doi:10.1053/j.ajkd.2003.12.005. [PubMed] [CrossRef] [Google Scholar]

108. Klein E., Ward R. A., Harding G. B. Calcium carbonate precipitation in bicarbonate hemodialysis. Artificial Organs. 1986;10(3):248–250. doi:10.1111/j.1525-1594.1986.tb02554.x. [PubMed] [CrossRef] [Google Scholar]

109. Neuman W. F., Morrow P. E., Toribara T. Y., Casarett L. J., Mulryan B. J., Hodge H. C. Evidence for complex ion formation in the calcium-bicarbonate system. The Journal of Biological Chemistry. 1956;219(2):551–555. [PubMed] [Google Scholar]

110. Pedersen K. O. The effect of bicarbonate, PCO2 and pH on serum calcium fractions. Scandinavian Journal of Clinical and Laboratory Investigation. 1971;27:145–150. [PubMed] [Google Scholar]

111. Chang X., Zheng Y., Yang Q., Wang L., Pan J., Xia Y., Yan X., Han J. Carbonic anhydrase I (CA1) is involved in the process of bone formation and is susceptible to ankylosing spondylitis. Arthritis Research and Therapy. 2012;14(4, article R176) doi:10.1186/ar3929. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

112. Müller W. E. G., Schröder H. C., Schlossmacher U., Grebenjuk V. A., Ushijima H., Wang X. Induction of carbonic anhydrase in SaOS-2 cells, exposed to bicarbonate and consequences for calcium phosphate crystal formation. Biomaterials. 2013;34(34):8671–8680. doi:10.1016/j.biomaterials.2013.07.096. [PubMed] [CrossRef] [Google Scholar]

113. Soler N. G., Bennett M. A., FitzGerald M. G., Malins J. M. Successful resuscitation in diabetic ketoacidosis: a strong case for the use of bicarbonate. Postgraduate Medical Journal. 1974;50(585):465–468. doi:10.1136/pgmj.50.585.465. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

114. Munk P., Freedman M. H., Levison H., Ehrlich R. M. Effect of bicarbonate on oxygen transport in juvenile diabetic ketoacidosis. Journal of Pediatrics. 1974;84(4):510–514. doi:10.1016/S0022-3476(74)80669-4. [PubMed] [CrossRef] [Google Scholar]

115. Ritter J. M., Doktor H. S., Benjamin N. Paradoxial effect of bicarbonate on cytoplasmic pH. The Lancet. 1990;335(8700):1243–1246. doi:10.1016/0140-6736(90)91305-T. [PubMed] [CrossRef] [Google Scholar]

116. Goldsmith D. J. A., Forni L. G., Hilton P. J. Bicarbonate therapy and intracellular acidosis. Clinical Science. 1997;93(6):593–598. [PubMed] [Google Scholar]

117. Mattar J. A., Weil M. H., Shubin H., Stein L. Cardiac arrest in the critically ill. II. Hyperosmolal states following cardiac arrest. The American Journal of Medicine. 1974;56(2):162–168. doi:10.1016/0002-9343(74)90593-2. [PubMed] [CrossRef] [Google Scholar]

118. Pichette C., Bercovici M., Goldstein M., Stinebaugh B., Tam S. C., Halperin M. Elevation of the blood lactate concentration by alkali therapy without requiring additional lactic acid accumulation: theoretical considerations. Critical Care Medicine. 1982;10(5):323–326. doi:10.1097/00003246-198205000-00008. [PubMed] [CrossRef] [Google Scholar]

119. Luft F. C., Zemel M. B., Sowers J. A., Weinberger N. S. M. H. F. Sodium bicarbonate and sodium chloride: effects on blood pressure and electrolyte homeostasis in normal and hypertensive man. Journal of Hypertension. 1990;8(7):663–670. doi:10.1097/00004872-199007000-00010. [PubMed] [CrossRef] [Google Scholar]

Sodium Bicarbonate Therapy in Patients with Metabolic Acidosis (2024)

FAQs

How is sodium bicarbonate used for metabolic acidosis? ›

The main therapeutic effect of sodium bicarbonate administration is increasing plasma bicarbonate levels, which are known to buffer excess hydrogen ion concentration, thereby raising solution pH to combat clinical manifestations of acidosis.

What is the most appropriate therapy for the metabolic acidosis? ›

If changes to your diet are not enough, your healthcare professional may recommend adding medication. The most commonly prescribed medications (supplements) for metabolic acidosis include: Sodium bicarbonate tablets. Sodium bicarbonate powder (also known as baking soda)

What are two conditions a sodium bicarbonate infusion could be used for? ›

4.1 Therapeutic indications Sodium bicarbonate is used as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, Addison's disease or administration of ...

What do you give a patient with metabolic acidosis? ›

One way to increase bicarbonate levels is through alkali therapy, which could include taking sodium bicarbonate. Your doctor could also suggest taking another similar supplement, such as calcium citrate, calcium carbonate, or calcium acetate. Taking sodium bicarbonate introduces sodium (salt) into your body.

How do you correct severe metabolic acidosis? ›

HCO3- therapy can be administered to correct severe acidosis, but large amounts of HCO3- may be required and fluid overload can compromise therapy. Patients with methanol overdose should receive folate to enhance the metabolism of formic acid.

How much sodium bicarbonate to raise pH? ›

A rule of thumb is 1.5 lbs. of baking soda per 10,000 gallons of water will raise alkalinity by about 10 ppm. If your pool's pH tested below 7.2, add 3-4 pounds of baking soda. If you're new to adding pool chemicals, start by adding only one-half or three-fourths of the recommended amount.

What is the first line treatment for metabolic acidosis? ›

What medications are used to treat metabolic acidosis? The over-the-counter (OTC) medications sodium citrate or sodium bicarbonate can help balance the acids in your body.

What are the interventions for metabolic acidosis? ›

These interventions involve the administration of specific medications that target the root causes of acidosis, promote acid excretion, and restore the body's acid-base balance. Sodium bicarbonate, a common intervention, is administered intravenously to raise serum bicarbonate levels and neutralize excess acids.

Which medication reverses metabolic acidosis? ›

Medication Summary

Sodium bicarbonate (NaHCO3) is the agent most commonly used to correct metabolic acidosis.

When should you not use sodium bicarbonate? ›

People who already have high levels of sodium in the blood should avoid sodium bicarbonate. High blood pressure: Sodium bicarbonate might increase blood pressure. People who already have high blood pressure should avoid sodium bicarbonate.

When would you give a patient sodium bicarbonate? ›

Sodium bicarbonate , also known as baking soda, is used to relieve heartburn, sour stomach, or acid indigestion by neutralizing excess stomach acid. When used for this purpose, it is said to belong to the group of medicines called antacids. It may be used to treat the symptoms of stomach or duodenal ulcers.

What does sodium bicarb do to the heart? ›

In a study of patients with congestive heart failure, the administration of bicarbonate reduced systemic and myocardial oxygen consumption, increased mixed venous carbon dioxide, but most impressively increased myocardial lactate production.

How does sodium bicarbonate help metabolic acidosis? ›

Sodium bicarbonate infusion reduces plasma ionized calcium concentration in critically ill patients with metabolic acidosis [21, 38]. In vitro, bicarbonate concentration has a major effect reducing ionized calcium level in serum [96].

How should metabolic acidosis be most commonly treated? ›

IV sodium bicarbonate

Adding base to counter high acids levels treats some types of metabolic acidosis. Intravenous (IV) treatment with a base called sodium bicarbonate is one way to balance acids in the blood. It 's used to treat conditions that cause acidosis through bicarbonate (base) loss.

How do you calculate sodium bicarbonate correction in metabolic acidosis? ›

All doses are written in millimoles of sodium bicarbonate. Determined by base deficit Full Correction Dose (mmol) = 0.3 x base deficit (mmol/L) x wt(kg) Administer half of the calculated dose, and then assess the need for remainder.

How does sodium bicarbonate neutralize acid? ›

Sodium bicarbonate is a salt that breaks down to form sodium and bicarbonate in water. This breakdown makes a solution alkaline, meaning it is able to neutralize acid. Because of this, sodium bicarbonate is often used to treat conditions caused by high acidity in the body, such as heartburn.

How does sodium bicarbonate reduce acid? ›

It works because it has an alkaline pH, which helps to neutralize the acidity in your stomach, working in a similar manner to many over-the-counter antacids. Consult your physician before using baking soda regularly, as it can affect the absorption of many medications, and is high in sodium.

How is sodium bicarbonate administered in respiratory acidosis? ›

Bicarbonate. Infusion of sodium bicarbonate is rarely indicated. This measure may be considered after cardiopulmonary arrest with an extremely low pH (< 7.0-7.1). In most other situations, sodium bicarbonate has no role in the treatment of respiratory acidosis.

How does the bicarbonate buffer system work to counteract acidosis? ›

When the pH of the blood starts to get too low (there are too many H+ ions in the blood), the bicarbonate ion will pick up a H+ ion and become carbonic acid. That carbonic acid, in turn, will split apart into carbon dioxide, which is exhaled through the lungs, and water.

Top Articles
Latest Posts
Article information

Author: Rev. Leonie Wyman

Last Updated:

Views: 5701

Rating: 4.9 / 5 (59 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Rev. Leonie Wyman

Birthday: 1993-07-01

Address: Suite 763 6272 Lang Bypass, New Xochitlport, VT 72704-3308

Phone: +22014484519944

Job: Banking Officer

Hobby: Sailing, Gaming, Basketball, Calligraphy, Mycology, Astronomy, Juggling

Introduction: My name is Rev. Leonie Wyman, I am a colorful, tasty, splendid, fair, witty, gorgeous, splendid person who loves writing and wants to share my knowledge and understanding with you.